MYC and breast cancer: A similar switch from glycolysis to OXPHOS has also been documented upon MYC/KRAS or MYC/ERBB2 ablation in breast cancer cells174, and in the context of acquired resistance to phosphoinositide-3-kinase (PI3K) inhibition in glioma cells175.